Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca and Targacept Initiate Phase 3 Clinical Development of TC-5214 as an Adjunct Treatment for Major Depressive Disorder
-
Federal Court of Canada Rules on Applications for Generic Esomeprazole Magnesium
-
AstraZeneca Submits Marketing Authorisation Application To European Union For Cardiovascular Drug Axanum
-
FDA Advisory Committee Reviews MedImmune’s Motavizumab
-
FDA updates US product labels for LABA-containing medications including AstraZeneca’s SYMBICORT
-
AstraZeneca Receives FDA Complete Response Letter for AXANUM New Drug Application
-
AstraZeneca Announces Results of Recentin HORIZON II Phase III Trial in Metastatic Colorectal Cancer
-
NOTICE: Advisory Committee Briefing Materials for Motavizumab BLA Available on US FDA Web Site
-
Martin Mackay to Lead AstraZeneca's Research and Development Organisation
-
AstraZeneca Reaches US Agreement With Teva Pharmaceuticals Regarding Entocort EC Capsules
Latest articles and press releases
All of our latest press releases and articles are available to explore
